|
1
|
Takeuchi K and Shimizu K: Hypoplasia of
the bilateral internal carotid arteries. Brain Nerve. 9:37–43.
1957.
|
|
2
|
Suzuki J and Takaku A: Cerebrovascular
‘moyamoya’ disease. Disease showing abnormal net-like vessels in
base of brain. Arch Neurol. 20:288–299. 1969. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kuroda S and Houkin K: Moyamoya disease:
Current concepts and future perspectives. Lancet Neurol.
7:1056–1066. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fukui M: Guidelines for the diagnosis and
treatment of spontaneous occlusion of the circle of Willis
(moyamoya' disease). Research committee on spontaneous occlusion of
the circle of Willis (moyamoya disease) of the ministry of health
and welfare, Japan. Clin Neurol Neurosurg. 99 (Suppl 2):S238–S240.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Research Committee on the Pathology and
Treatment of Spontaneous Occlusion of the Circle of Willis; Health
Labour Sciences Research Grant for Research on Measures for
Infractable Diseases: Guidelines for diagnosis and treatment of
moyamoya disease (spontaneous occlusion of the circle of Willis).
Neurol Med Chir (Tokyo). 52:245–266. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Syndrome Cecgodatomdam and Committee
TNCoHS PatoissecoS: Chinese expert consensus on diagnosis and
treatment of moyamoya disease and moyamoya syndrome (2017). Chin J
Neurosurg. 6:541–547. 2017.(In Chinese).
|
|
7
|
Research on intractable diseases of the
Ministry of Health Labour and Welfare, Japan: Recommendations for
the management of moyamoya disease: A statement from research
committee on spontaneous occlusion of the circle of Willis
(moyamoya disease). Surgery for Cerebral Stroke. 37:321–337. 2009.
View Article : Google Scholar
|
|
8
|
Piao J, Wu W, Yang Z and Yu J: Research
progress of moyamoya disease in children. Int J Med Sci.
12:566–575. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Smith ER and Scott RM: Spontaneous
occlusion of the circle of Willis in children: Pediatric moyamoya
summary with proposed evidence-based practice guidelines. A review.
J Neurosurg Pediatr. 9:353–360. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Khan N, Achrol AS, Guzman R, Burns TC,
Dodd R, Bell-Stephens T and Steinberg GK: Sex differences in
clinical presentation and treatment outcomes in Moyamoya disease.
Neurosurgery. 71:587–593. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim T, Lee H, Bang JS, Kwon OK, Hwang G
and Oh CW: Epidemiology of moyamoya disease in Korea: Based on
national health insurance service data. J Korean Neurosurg Soc.
57:390–395. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou XW, Wang JZ and Ma Y: Literature
review and current situation of domestic moyamoya disease. Chin J
Pract Nerv Dis. 20:1–4. 2017.
|
|
13
|
Seol HJ, Wang KC, Kim SK, Hwang YS, Kim KJ
and Cho BK: Headache in pediatric moyamoya disease: Review of 204
consecutive cases. J Neurosurg. 103 Suppl 5:S439–S442. 2005.
|
|
14
|
Okada Y, Kawamata T, Kawashima A,
Yamaguchi K, Ono Y and Hori T: The efficacy of superficial temporal
artery-middle cerebral artery anastomosis in patients with moyamoya
disease complaining of severe headache. J Neurosurg. 116:672–679.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Baba T, Houkin K and Kuroda S: Novel
epidemiological features of moyamoya disease. J Neurol Neurosurg
Psychiatry. 79:900–904. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ahn IM, Park DH, Hann HJ, Kim KH, Kim HJ
and Ahn HS: Incidence, prevalence, and survival of moyamoya disease
in Korea: A nationwide, population-based study. Stroke.
45:1090–1095. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kainth D, Chaudhry SA, Kainth H, Suri FK
and Qureshi AI: Epidemiological and clinical features of moyamoya
disease in the USA. Neuroepidemiology. 40:282–287. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Miao W, Zhao PL, Zhang YS, Liu HY, Chang
Y, Ma J, Huang QJ and Lou ZX: Epidemiological and clinical features
of Moyamoya disease in Nanjing, China. Clin Neurol Neurosurg.
112:199–203. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Duan L, Bao XY, Yang WZ, Shi WC, Li DS,
Zhang ZS, Zong R, Han C, Zhao F and Feng J: Moyamoya disease in
China: Its clinical features and outcomes. Stroke. 43:56–60. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mineharu Y, Takenaka K, Yamakawa H, Inoue
K, Ikeda H, Kikuta KI, Takagi Y, Nozaki K, Hashimoto N and Koizumi
A: Inheritance pattern of familial moyamoya disease: Autosomal
dominant mode and genomic imprinting. J Neurol Neurosurg
Psychiatry. 77:1025–1029. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ikeda H, Sasaki T, Yoshimoto T, Fukui M
and Arinami T: Mapping of a familial moyamoya disease gene to
chromosome 3p24.2-p26. Am J Hum Genet. 64:533–537. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yamauchi T, Tada M, Houkin K, Tanaka T,
Nakamura Y, Kuroda S, Abe H, Inoue T, Ikezaki K, Matsushima T and
Fukui M: Linkage of familial moyamoya disease (spontaneous
occlusion of the circle of Willis) to chromosome 17q25. Stroke.
31:930–935. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sakurai K, Horiuchi Y, Ikeda H, Ikezaki K,
Yoshimoto T, Fukui M and Arinami T: A novel susceptibility locus
for moyamoya disease on chromosome 8q23. J Hum Genet. 49:278–281.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kamada F, Aoki Y, Narisawa A, Abe Y,
Komatsuzaki S, Kikuchi A, Kanno J, Niihori T, Ono M, Ishii N, et
al: A genome-wide association study identifies RNF213 as the first
Moyamoya disease gene. J Hum Genet. 56:34–40. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu W, Morito D, Takashima S, Mineharu Y,
Kobayashi H, Hitomi T, Hashikata H, Matsuura N, Yamazaki S, Toyoda
A, et al: Identification of RNF213 as a susceptibility gene for
moyamoya disease and its possible role in vascular development.
PLoS One. 6:e225422011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu Z, Jiang H, Zhang L, Xu X, Zhang X,
Kang Z, Song D, Zhang J, Guan M and Gu Y: Molecular analysis of
RNF213 gene for moyamoya disease in the Chinese Han population.
PLoS One. 7:e481792012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Miyatake S, Miyake N, Touho H,
Nishimura-Tadaki A, Kondo Y, Okada I, Tsurusaki Y, Doi H, Sakai H,
Saitsu H, et al: Homozygous c.14576G>A variant of RNF213
predicts early-onset and severe form of moyamoya disease.
Neurology. 78:803–810. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cecchi AC, Guo D, Ren Z, Flynn K,
Santos-Cortez RL, Leal SM, Wang GT, Regalado ES, Steinberg GK,
Shendure J, et al: RNF213 rare variants in an ethnically diverse
population with Moyamoya disease. Stroke. 45:3200–3207. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim EH, Yum MS, Ra YS, Park JB, Ahn JS,
Kim GH, Goo HW, Ko TS and Yoo HW: Importance of RNF213 polymorphism
on clinical features and long-term outcome in moyamoya disease. J
Neurosurg. 124:1221–1227. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kobayashi H, Brozman M, Kyselová K,
Viszlayová D, Morimoto T, Roubec M, Školoudík D, Petrovičová A,
Juskanič D, Strauss J, et al: RNF213 rare variants in slovakian and
czech moyamoya disease patients. PLoS One. 11:e01647592016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Raso A, Biassoni R, Mascelli S, Nozza P,
Ugolotti E, DI Marco E, DE Marco P, Merello E, Cama A, Pavanello M
and Capra V: Moyamoya vasculopathy shows a genetic mutational
gradient decreasing from East to West. J Neurosurg Sci.
2016.PubMed/NCBI
|
|
32
|
Guey S, Kraemer M, Hervé D, Ludwig T,
Kossorotoff M, Bergametti F, Schwitalla JC, Choi S, Broseus L,
Callebaut I, et al: Rare RNF213 variants in the C-terminal region
encompassing the RING-finger domain are associated with moyamoya
angiopathy in Caucasians. Eur J Hum Genet. 25:995–1003. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li H, Zhang ZS, Liu W, Yang WZ, Dong ZN,
Ma MJ, Han C, Yang H, Cao WC and Duan L: Association of a
functional polymorphism in the MMP-3 gene with Moyamoya disease in
the Chinese Han population. Cerebrovasc Dis. 30:618–625. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hishikawa T, Tokunaga K, Sugiu K and Date
I: Assessment of the difference in posterior circulation
involvement between pediatric and adult patients with moyamoya
disease. J Neurosurg. 119:961–965. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fujimura M and Tominaga T: Lessons learned
from moyamoya disease: Outcome of direct/indirect revascularization
surgery for 150 affected hemispheres. Neurol Med Chir (Tokyo).
52:327–332. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mugikura S, Takahashi S, Higano S, Shirane
R, Sakurai Y and Yamada S: Predominant involvement of ipsilateral
anterior and posterior circulations in moyamoya disease. Stroke.
33:1497–1500. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mugikura S, Takahashi S, Higano S, Shirane
R, Kurihara N, Furuta S, Ezura M and Takahashi A: The relationship
between cerebral infarction and angiographic characteristics in
childhood moyamoya disease. AJNR Am J Neuroradiol. 20:336–343.
1999.PubMed/NCBI
|
|
38
|
Houkin K, Nakayama N, Kuroda S, Nonaka T,
Shonai T and Yoshimoto T: Novel magnetic resonance angiography
stage grading for moyamoya disease. Cerebrovasc Dis. 20:347–354.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ryoo S, Cha J, Kim SJ, Choi JW, Ki CS, Kim
KH, Jeon P, Kim JS, Hong SC and Bang OY: High-resolution magnetic
resonance wall imaging findings of Moyamoya disease. Stroke.
45:2457–2460. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
So Y, Lee HY, Kim SK, Lee JS, Wang KC, Cho
BK, Kang E and Lee DS: Prediction of the clinical outcome of
pediatric moyamoya disease with postoperative basal/acetazolamide
stress brain perfusion SPECT after revascularization surgery.
Stroke. 36:1485–1489. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tanaka Y, Nariai T, Nagaoka T, Akimoto H,
Ishiwata K, Ishii K, Matsushima Y and Ohno K: Quantitative
evaluation of cerebral hemodynamics in patients with moyamoya
disease by dynamic susceptibility contrast magnetic resonance
imaging-comparison with positron emission tomography. J Cereb Blood
Flow Metab. 26:291–300. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Federau C, Christensen S, Zun Z, Park SW,
Ni W, Moseley M and Zaharchuk G: Cerebral blood flow, transit time,
and apparent diffusion coefficient in moyamoya disease before and
after acetazolamide. Neuroradiology. 59:5–12. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen JC, Liu B, Li ZW, Yu JS, He Y and
Chen RD: Using CT perfusion imaging to evaluate the effect of
STA-MCA bypass on hemorrhagic moyamoya disease. Chin J Neurosurg.
25:537–540. 2009.
|
|
44
|
Wang B, Zhou Q, Yao ZW, Li ZY and He GW:
CTP and PWI in assessment of the effect of cerebral
revascularization for moyamoya disease. Chin Comput Med imag.
21:64–68. 2015.
|
|
45
|
Nakagawara J: Reconsideration of
hemodynamic cerebral ischemia using recent PET/SPECT studies.
Trends in Cerebrovascular Surgery (Springer). 99–108. 2016.
View Article : Google Scholar
|
|
46
|
Takagi Y, Kikuta K, Nozaki K, Fujimoto M,
Hayashi J, Imamura H and Hashimoto N: Expression of
hypoxia-inducing factor-1 alpha and endoglin in intimal hyperplasia
of the middle cerebral artery of patients with Moyamoya disease.
Neurosurgery. 60:338–345. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Takagi Y, Kikuta K, Nozaki K and Hashimoto
N: Histological features of middle cerebral arteries from patients
treated for Moyamoya disease. Neurol Med Chir (Tokyo). 47:1–4.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chmelova J, Kolar Z, Prochazka V, Curik R,
Dvorackova J, Sirucek P, Kraft O and Hrbac T: Moyamoya disease is
associated with endothelial activity detected by anti-nestin
antibody. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub.
154:159–162. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Guo DC, Papke CL, Tran-Fadulu V, Regalado
ES, Avidan N, Johnson RJ, Kim DH, Pannu H, Willing MC, Sparks E, et
al: Mutations in smooth muscle alpha-actin (ACTA2) cause coronary
artery disease, stroke, and Moyamoya disease, along with thoracic
aortic disease. Am J Hum Genet. 84:617–627. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kumar AH and Caplice NM: Clinical
potential of adult vascular progenitor cells. Arterioscler Thromb
Vasc Biol. 30:1080–1087. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kim JH, Jung JH, Phi JH, Kang HS, Kim JE,
Chae JH, Kim SJ, Kim YH, Kim YY, Cho BK, et al: Decreased level and
defective function of circulating endothelial progenitor cells in
children with moyamoya disease. J Neurosci Res. 88:510–518.
2010.PubMed/NCBI
|
|
52
|
Lee JY, Moon YJ, Lee HO, Park AK, Choi SA,
Wang KC, Han JW, Joung JG, Kang HS, Kim JE, et al: Deregulation of
retinaldehyde dehydrogenase 2 leads to defective angiogenic
function of endothelial colony-forming cells in pediatric moyamoya
disease. Arterioscler Thromb Vasc Biol. 35:1670–1677. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kim SJ, Heo KG, Shin HY, Bang OY, Kim GM,
Chung CS, Kim KH, Jeon P, Kim JS, Hong SC and Lee KH: Association
of thyroid autoantibodies with moyamoya-type cerebrovascular
disease: A prospective study. Stroke. 41:173–176. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Sigdel TK, Shoemaker LD, Chen R, Li L,
Butte AJ, Sarwal MM and Steinberg GK: Immune response profiling
identifies autoantibodies specific to Moyamoya patients. Orphanet J
Rare Dis. 8:452013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Sakamoto S, Kiura Y, Yamasaki F, Shibukawa
M, Ohba S, Shrestha P, Sugiyama K and Kurisu K: Expression of
vascular endothelial growth factor in dura mater of patients with
moyamoya disease. Neurosurg Rev. 31:77–81. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Furuno A, Watari K, Nakamura M, Fukunaga
Y, Jung JH and Ono M: A natural anti-inflammatory enone fatty acid
inhibits angiogenesis by attenuating nuclear factor-κB signaling in
vascular endothelial cells. Int J Oncol. 38:493–501.
2011.PubMed/NCBI
|
|
57
|
Kang HS, Kim JH, Phi JH, Kim YY, Kim JE,
Wang KC, Cho BK and Kim SK: Plasma matrix metalloproteinases,
cytokines and angiogenic factors in moyamoya disease. J Neurol
Neurosurg Psychiatry. 81:673–678. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Jeon JS, Ahn JH, Moon YJ, Cho WS, Son YJ,
Kim SK, Wang KC, Bang JS, Kang HS, Kim JE and Oh CW: Expression of
cellular retinoic acid-binding protein-I (CRABP-I) in the
cerebrospinal fluid of adult onset moyamoya disease and its
association with clinical presentation and postoperative
haemodynamic change. J Neurol Neurosurg Psychiatry. 85:726–731.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Fung LW, Thompson D and Ganesan V:
Revascularisation surgery for paediatric moyamoya: A review of the
literature. Childs Nerv Syst. 21:358–364. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Guzman R, Lee M, Achrol A, Bell-Stephens
T, Kelly M, Do HM, Marks MP and Steinberg GK: Clinical outcome
after 450 revascularization procedures for moyamoya disease.
Clinical article. J Neurosurg. 111:927–935. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Hallemeier CL, Rich KM, Grubb RL Jr,
Chicoine MR, Moran CJ, Cross DT III, Zipfel GJ, Dacey RG Jr and
Derdeyn CP: Clinical features and outcome in North American adults
with moyamoya phenomenon. Stroke. 37:1490–1496. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Scott RM, Smith JL, Robertson RL, Madsen
JR, Soriano SG and Rockoff MA: Long-term outcome in children with
moyamoya syndrome after cranial revascularization by pial
synangiosis. J Neurosurg. 100 (2 Suppl Pediatrics):S142–S149.
2004.
|
|
63
|
Miyamoto S, Yoshimoto T, Hashimoto N,
Okada Y, Tsuji I, Tominaga T, Nakagawara J and Takahashi JC; JAM
Trial Investigators, : Effects of extracranial-intracranial bypass
for patients with hemorrhagic moyamoya disease: Results of the
Japan Adult Moyamoya Trial. Stroke. 45:1415–1421. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Wan M and Duan L: Recent progress in
hemorrhagic moyamoya disease. Br J Neurosurg. 29:189–191. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Huang Z, Ding X, Men W, Zhang D, Zhao Y,
Wang R, Wang S and Zhao J: Clinical features and outcomes in 154
patients with haemorrhagic moyamoya disease: Comparison of
conservative treatment and surgical revascularization. Neurol Res.
37:886–892. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Lee SU, Oh CW, Kwon OK, Bang JS, Ban SP,
Byoun HS and Kim T: Surgical treatment of adult moyamoya disease.
Curr Treat Options Neurol. 20:222018. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Kawashima A, Kawamata T, Yamaguchi K, Hori
T and Okada Y: Successful superficial temporal artery-anterior
cerebral artery direct bypass using a long graft for moyamoya
disease. Neurosurgery. 67 (3 Suppl Operative):ons145–ons149.
2010.PubMed/NCBI
|
|
68
|
Hayashi T, Shirane R and Tominaga T:
Additional surgery for postoperative ischemic symptoms in patients
with moyamoya disease: The effectiveness of occipital
artery-posterior cerebral artery bypass with an indirect procedure:
Technical case report. Neurosurgery. 64:E195–E196. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Karasawa J, Kikuchi H, Furuse S, Sakaki T
and Yoshida Y: A surgical treatment of ‘moyamoya’ disease
‘encephalo-myo synangiosis’. Neurol Med Chir (Tokyo). 17:29–37.
1977. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Matsushima Y, Aoyagi M, Koumo Y, Takasato
Y, Yamaguchi T, Masaoka H, Suzuki R and Ohno K: Effects of
encephalo-duro-arterio-synangiosis on childhood Moyamoya patients.
Neurol Med Chir (Tokyo). 31:708–714. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Endo M, Kawano N, Miyaska Y and Yada K:
Cranial burr hole for revascularization in moyamoya disease. J
Neurosurg. 71:180–185. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Kinugasa K, Mandai S, Tokunaga K, Kamata
I, Sugiu K, Handa A and Ohmoto T: Ribbon
enchephalo-duro-arterio-myo-synangiosis for moyamoya disease. Surg
Neurol. 41:455–461. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Kuroda S, Houkin K, Ishikawa T, Nakayama N
and Iwasaki Y: Novel bypass surgery for moyamoya disease using
pericranial flap: Its impacts on cerebral hemodynamics and
long-term outcome. Neurosurgery. 66:1093–1101. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Karasawa J, Kikuchi H, Kawamura J and
Sakai T: Intracranial transplantation of the omentum for
cerebrovascular moyamoya disease: A two-year follow-up study. Surg
Neurol. 14:444–449. 1980.PubMed/NCBI
|
|
75
|
Kim H, Jang DK, Han YM, Sung JH, Park IS,
Lee KS, Yang JH, Huh PW, Park YS, Kim DS and Han KD: Direct bypass
versus indirect bypass in adult moyamoya angiopathy with symptoms
or hemodynamic instability: A meta-analysis of comparative studies.
World Neurosurg. 94:273–284. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Iwama T, Hashimoto N and Yonekawa Y: The
relevance of hemodynamic factors to perioperative ischemic
complications in childhood moyamoya disease. Neurosurgery.
38:1120–1126. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Mukerji N, Cook DJ and Steinberg GK: Is
local hypoperfusion the reason for transient neurological deficits
after STA-MCA bypass for moyamoya disease? J Neurosurg. 122:90–94.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Fujimura M, Mugikura S, Kaneta T, Shimizu
H and Tominaga T: Incidence and risk factors for symptomatic
cerebral hyperperfusion after superficial temporal artery-middle
cerebral artery anastomosis in patients with moyamoya disease. Surg
Neurol. 71:442–447. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Kaku Y, Iihara K, Nakajima N, Kataoka H,
Fukuda K, Masuoka J, Fukushima K, Iida H and Hashimoto N: Cerebral
blood flow and metabolism of hyperperfusion after cerebral
revascularization in patients with moyamoya disease. J Cereb Blood
Flow Metab. 32:2066–2075. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Uchino H, Kuroda S, Hirata K, Shiga T,
Houkin K and Tamaki N: Predictors and clinical features of
postoperative hyperperfusion after surgical revascularization for
moyamoya disease: A serial single photon emission CT/positron
emission tomography study. Stroke. 43:2610–2616. 2012. View Article : Google Scholar : PubMed/NCBI
|
